Therapies
The Science
About us
Investors
News

Hit enter to search or ESC to close

Abstract from Movement Disorders Conference

June 22, 2016 Kerry Rowe

Abstract from Movement Disorders Conference 2016

Post navigation

Prana’s Huntington Disease trial analysis to feature at global movement disorder conference

Prana Alzheimer’s disease data features at world leading conference

Related Posts

Dr David Stamler China Investor & Partnering Symposium Webcast

March 15, 2018

Prana AGM Investor Conference Call

November 10, 2017

HCW&Co publishes Prana Reach2HD trial report, results “beat expectations”

February 24, 2014

Recent Posts

Quarterly Cash Flow Report
Alterity Therapeutics Announces Successful Completion of Phase 1 Clinical Trial
Alterity Therapeutics’ Finance News Network Presentation
Alterity Therapeutics talks to Finance News Network
Alterity Therapeutics Presents to Finance News Network

Recent Comments

Archives

Archives

Categories

Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Therapies
The Science
About us
Investors
News
Contact us

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065